Hepatitis C: Current Status and Future Directions for Antiviral Therapy
Reference85 articles.
1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359–362 2. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee W-S, Kuo C, Berger K, Shuster JR, Overby LR, Bradley DW, Houghton M (1989) An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362–364 3. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ (1992) The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899–1905 4. Jeffers LJ, Hasan F, de Medina M, Reddy R, Parker T, Silva M, Mendez L, Schiff ER, Manns M, Houghton M, Choo Q-L, Kuo G (1992) Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis. Hepatology 15:187–190 5. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo Q-L, Houghton M, Kuo G (1991) Hepatitis C virusinfection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87:6547–6549
|
|